Compliance, Regulatory Requirements 28 Jan 2025 compliance, regulation, securities, financial reporting, treasury, data collection

📊Treasury Data Collection on Foreign Security Holdings Notice

The Department of the Treasury will submit the following information collection requests to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. The public is invited to submit comments on these requests.

Learn More
Compliance, Trade Regulation 28 Jan 2025 compliance, commerce, international trade, antidumping, countervailing duty, u.s., glycine

⚖️Continuation of Antidumping and Countervailing Duty Orders on Glycine

As a result of the determinations by the U.S. Department of Commerce (Commerce) and the U.S. International Trade Commission (ITC) that revocation of the antidumping duty (AD) orders on glycine from India, Japan, and Thailand and countervailing duty (CVD) orders on glycine from India and the People's Republic of China (China), would likely lead to the continuation or recurrence of dumping, and material injury to an industry in the United States, Commerce is publishing a notice of continuation of these AD and CVD orders.

Learn More
Compliance, Financial Regulation 28 Jan 2025 sec, trading, securities, cboe, financial regulation, auction
Regulatory Compliance, Environmental Policy 28 Jan 2025 compliance, epa, air quality, environmental regulations, business impact, trichloroethylene

⏳Delay of EPA Regulation Dates

In accordance with the memorandum of January 20, 2025, from President Donald J. Trump, entitled "Regulatory Freeze Pending Review," this action temporarily delays until March 21, 2025, the effective date of the regulations listed in the table below. EPA has initially identified 4 regulations that meet the criteria in the memo and may identify additional regulations in subsequent notices.

Learn More
Compliance, Regulatory Requirements, Energy 28 Jan 2025 compliance, energy, federal regulations, business operations, rate filing
Compliance, Regulatory Update 28 Jan 2025 compliance, federal register, research, antitrust, blockchain, business standards
Compliance, Regulatory 28 Jan 2025 compliance, agriculture, regulations, aphis, horse protection, tennessee walking horse

🐎Analysis of Postponed Horse Protection Amendments and Business Impact

On May 8, 2024, we published a final rule amending the horse protection regulations to provide, among other provisions, that the Animal and Plant Health Inspection Service will screen, train, and authorize qualified persons for appointment by the management of any horse show, horse exhibition, or horse sale or auction to detect and diagnose soring at such events for the purposes of enforcing the Horse Protection Act. With the exception of Sec. 11.19, which went into effect on June 7, 2024, the remainder of the rule was scheduled to go into effect on February 1, 2025. In this document, we are issuing a temporary postponement of the effective date of those regulations for 60 days, from February 1, 2025 to April 2, 2025.

Learn More
Regulatory Compliance, Trade Implications 28 Jan 2025 countervailing duties, international trade, trade regulations, vietnam, paper products

📈Countervailing Duty Announcement on Paper Plates from Vietnam

The U.S. Department of Commerce (Commerce) determines that countervailable subsidies are being provided to producers and exporters of certain paper plates (paper plates) from the Socialist Republic of Vietnam (Vietnam) during the period of investigation, January 1, 2023, through December 31, 2023.

Learn More
Regulatory Compliance, Trade Regulations 28 Jan 2025 compliance, international trade, countervailing duty, u.s. department of commerce, slag pots, subsidy
Regulatory Compliance, Pharmaceuticals 28 Jan 2025 regulatory compliance, pharmaceuticals, importation, dea, controlled substances, vici health sciences

📋DEA Notice

Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More